Abstract:Depression is a mental disease that involves a variety of complex physiological mechanisms. A wide range of methods have therefore been used to establish mouse models of depression, and there are currently many ways to develop such mouse models. The present study aimed to compare the effects of various model induction methods and assesses their different effects. To this end, C57BL/6J mice were divided into three experimental groups: the chronic restraint stress (CRS) group received 6 hours of daily confinement within restraint tubes over a 3-week period; the chronic lipopolysaccharide (C-LPS) administration group received daily intraperitoneal injections of 0.5 mg/kg LPS for 1 week; and the acute LPS (A-LPS) administration group received a singular intraperitoneal injection of 0.83 mg/kg LPS. A corresponding control group was established for each experimental condition. Following mouse model establishment, depression-like behaviors were assessed through the forced swimming and tail suspension tests; anxiety-related behaviors were evaluated using the open field test and elevated plus maze. Furthermore, the expression of the immediate early gene c-Fos, ionized calcium-binding adapter molecule 1 (IBA1), and glial fibrillary acidic protein (GFAP) was examined via immunofluorescence. Longer immobility durations during the forced swimming and tail suspension tests were observed across all model groups (p < 0.05), indicating depression-like behaviors. Furthermore, the CRS and C-LPS group, but not the A-LPS group, showed significant anxiety-like behaviors in the elevated plus maze (p < 0.05). All model groups also exhibited significant increases in both time and distance explored within the central area of the open field test (p < 0.05). The activation of GFAP- and IBA1-positive cells in the cerebral cortex and hippocampus was also markedly pronounced in all experimental groups, suggesting the association of neuroinflammatory responses with induced depressive states. The present findings contribute to our understanding of the pathophysiology of stress-induced and neuroinflammatory-associated depression, and will help researchers to choose suitable depression models for their investigations.

Depression-like Behavior Induced by Repeated Administration of Dexamethasone to Lipopolysaccharide-inflamed Mice

Long-term effects of a single high-dose intraperitoneal injection of lipopolysaccharide on depression-like behavior in adolescent mice

Comparison of Chronic Restraint Stress- and Lipopolysaccharide-Induced Mouse Models of Depression: Behavior, C-Fos Expression, and Microglial and Astrocytic Activation

Predictable Chronic Mild Stress Promotes Recovery from LPS-induced Depression

A New Animal Model of (chronic) Depression Induced by Repeated and Intermittent Lipopolysaccharide Administration for 4Months

CUMS and Dexamethasone Induce Depression-Like Phenotypes in Mice by Differentially Altering Gut Microbiota and Triggering Macroglia Activation

A new mouse model of depression induced by chronic restraint stress combined with lipopolysaccharide

A Study on the Depressive Behavior and Cognitive Dysfunction Induced by Consecutive Injection of Lipopolysaccharide

A Mouse Model of Depression Induced by Repeated Corticosterone Injections.

Lipopolysaccharide-induced depression-like model in mice: meta-analysis and systematic evaluation

Dynamic Microglial Activation is Associated with LPS-induced Depressive-like Behavior in Mice: an [18F] DPA-714 PET Imaging Study

Dlg1 deletion in microglia ameliorates chronic restraint stress induced mice depression-like behavior

Effects of dexmedetomidine on depression-like behaviour in chronic restraint stress mice: Involvement of specific brain regions

Post-inflammatory behavioural despair in male mice is associated with reduced cortical glutamate-glutamine ratios, and circulating lipid and energy metabolites

Saikosaponin-d attenuated lipopolysaccharide-induced depressive-like behaviors via inhibiting microglia activation and neuroinflammation

Major Depression Model Induced by Repeated and Intermittent Lipopolysaccharide Administration: Long-lasting Behavioral, Neuroimmune and Neuroprogressive Alterations.

Effect of ketamine combined with DHA on lipopolysaccharide-induced depression-like behavior in rats.

Dexmedetomidine Alleviates Lipopolysaccharide-Induced Hippocampal Neuronal Apoptosis Via Inhibiting the P38 MAPK/c-Myc/CLIC4 Signaling Pathway in Rats

The Dopamine Receptor D3 Regulates Lipopolysaccharide-Induced Depressive-Like Behavior in Mice

Comparison of LPS and MS-induced depressive mouse model: behavior, inflammation and biochemical changes

Repetitive Administration of Low-Dose Lipopolysaccharide Improves Repeated Social Defeat Stress-Induced Behavioral Abnormalities and Aberrant Immune Response